Some glaring highlights from the last 3 earnings reports:

Q4 2021:
Revenues of $7.2MM
Backlog of signed and/or awarded contracts of $47.7MM

Q1 2022:
Revenues of $4,206,762,
Backlog of signed and/or awarded contracts of $41.2MM


Q2 2022:
Revenues of $5,847,180,
Backlog of signed and/or awarded contracts of $35.3M

Revenues in the first 2 quarters was $10,053,942, while backlog has declined by
$12.4 million

Not only does it appear on the surface that Pyrogenesis's revenues this year have been derived entirely from working off backlog, but it appears some orders have been canceled.

This doesn't prevent some novices here from their chant " Pyrogenesis is Growing!"

I believe that some here feel that the stock is cheap only because it's at $2 down from $12.00.

That doesn't mean squat.